Luogo e data di nascita: Roma, IT. 2 giugno 1963. Nazionalità Italiana
Posizioni attualiProfessore ordinario, Dipartimento di Neuroscienze Fondamentali (DNF),
CH - Vice-Decano per la ricerca e l'innovazione, Facoltà di Biologia e Medicina, Università di Losanna.
IT - Professore ordinario, Dipartimento di Biomedicina e Prevenzione, Facoltà di Medicina e Chirurgia. Università di Roma.
ORCID: orcid.org/0000-0002-4419-210X
Sito web:
https://wwwfbm.unil.ch/dnf/group/cellular-and-molecular-studies-of-synaptic- plasticità-e-cancro-nelle-disabilità-intellettive/member/bagni-claudia-bagni ISTRUZIONE ED ESPERIENZE PROFESSIONALI 1987 Laurea in Scienze Biologiche, Università di Roma “Tor Vergata”
1992 Dottorato di ricerca in Biologia Cellulare e Molecolare. Università di Roma "Tor Vergata" Supervisore del dottorato: Prof. Francesco Amaldi.
1991 – 1996 Periodo post-dottorato presso:
1- CNRS di Toulouse, Francia (1991-1993) nel laboratorio del Dr. Bruno Lapeyre e Dr. Michele Caizergues-Ferrer (EMBO Borsa di studio).
2- Biological Laboratories, Harvard University, Cambridge, USA (1991-1994) nel laboratorio del Prof. Fotis C. Kafatos (Fogarty-NIH Borsa di studio).
3- European Molecular Biological Laboratory (EMBL), Heidelberg, DE (1994-1995). prima presso il laboratorio del Prof. Fotis C. Kafatos (CEE-Human Capital Mobility Borsa di studio).
4- European Molecular Biological Laboratory (EMBL), Heidelberg, Germania (1995-1996) prima presso il laboratorio del Dr. Carlos Dotti (CEE-Human Capital Mobility Borsa di studio).
2011 Osservatore clinico presso il “M.I.N.D.” Institute, percorso formativo con la Dr.ssa Randi Hagerman, UC Davis California (USA).
CARRIERA1989 Abilitazione alla professione di Biologo.
1995-1999 Ricercatore in Biologia Molecolare (BIO11) presso il Dipartimento di Biologia, Facoltà di Scienze Matematiche, Fisiche e Naturali, Università di Roma “Tor Vergata”.
2002 Professore Associato in Biologia Molecolare (BIO11) presso il Dipartimento di Biologia, Facoltà di Scienze Matematiche, Fisiche e Naturali, Università di Roma “Tor Vergata”.
2003-2007 Group leader presso l’Istituto per le Neuroscienze Sperimentali, Fondazione Santa Lucia, IRCCS. Roma.
2007-oggi Professore Associato, Professore Ordinario in Biologia Applicata (BIO13) presso il Dipartimento di Biomedicina e prevenzione, Facoltà di Medicina e Chirurgia, Università di Roma “Tor Vergata”.
2008-2016 Professore ordinario presso la Università Cattolica di Lovanio (KU Leuven) & Group leader VIB (Flemish Institute for Biotechnology), Belgio.
2016-oggi Professore ordinario, Facoltà di Biologia e Medicina, Università di Losanna, Svizzera.
2016-2021 Direttore del Dipartimento di Neuroscienze Fondamentali (DNF), Università di Losanna, Svizzera.
2021- oggi Vice-Dean Ricerca ed Innovazione, Facoltà di Biologia e Medicina, Università di Losanna, Svizzera.
PREMI1991-2001
Borsa di studio NIH-Fogarty International Borsa di studio EMBO Long Term
Borsa di studio EMBO Short Term
Borsa di studio European Science Foundation Short Term Borsa di studio European Union-Human Capital Mobility Borsa di studio CNR (Italian NationalCouncil for Research)
2011 Queen Elisabeth Foundation Award (BE) 2011- oggi Eletta membro EMBO
2013 Premio Baron van Gysel de Meise (BE)
2013- oggi Socio onorario Associazione Italiana Sindrome X Fragile (IT) 2014 UCB (Union Chimique Belge) Award (BE)
2016 Premio Solvay (BE)
2017 Premio Pavoncella (Italia) - creatività scientifica femminile
2018 Nestle Research & Development (CH) – Women in Science Award 2020 Cittadinanza onoraria di Castelforte (IT)
2023 Comitato consultivo della Fragile X Associazione internazionale – FraXI (EU)
2023 CAVALIERE O.M.R.I. - Cavaliere dell'Ordine al Merito della Repubblica Italiana (IT)
ESPERTO IN COMITATI E MEMBRO SOCIETA’ SCIENTIFICHELeuven Research Institute for Neuroscience & Disease (LIND, 2010-2016).
Federation of European Neuroscience Societies (FENS).
Società Italiana di Biologia e Genetica (AIBG).
European Molecular and Cellular Cognition Society (EMCCS).
American Molecular and Cellular Cognition Society (MCCS).
Faculty of 1000 (www.facultyof1000.com) dal 2005-2008.
Collegio dei Docenti della scuola di dottorato in Neuroscienze, Università di Roma “Tor Vergata”.
REVISORE PER RIVISTE SCIENTIFICHECell, Nature, Science, J. Exp. Med., Lancet Neurol., Neuron, Nat. Neurosci., J. Neurosci., Cell Death Differ., Hum. Mol. Genet., J. Biol. Chem., Mol.Cell.Biol, Mol.Cell.Neurosci, Neuroscience, PLoS Biol, PLoS Genet, PLoS One, RNA, Trends Genet, Trends Neurosci., Trends Biochem.Sci., Nat. Rev. Neurosci., Proc. Natl. Acad. Sci. U.S.A., Dev. Cell, Neuropsychopharmacology, EMBO J., EMBO Rep., Nat. Commun., Mol.Psychiatry, Transl. Psychiatry, Glia, Brain.
ENTI DI FINANZIAMENTOEuropa: Fondation Recherche Medicale (FR); Fédération pour la Recherche sur le Cerveau (FR); Royal Netherlands Academy of Arts and Sciences (NL); French Centre National Recherche Scientifique ATIP (FR); Portuguese Foundation for Science and Technology (PT); Agence Nationale de la Recerche-ANR (FR); Fonds de la Recherche Scientifique (FNRS, FR); Swedish Research Council (SE); Fondi Investimenti Ricerca Base (FIRB, IT); Cancer Research UK (UK); Austrian Special Research Programs (SFBs, AT); Prinses Beatrix Fonds (NL); Wellcome Trust (UK); European Research Council (ERC); LundbeckFoundation (DK). EMBO Sostegno ai ricercatori post-dottorato in Europa e nel mondo (EMBL Interdisciplinary Postdoctoral Fellowships; EMBO Short Term Fellowships; EMBO Long Term Fellowships).
America: National Science Foundation (NSF); US-Israel Binational Science Foundation; Whitehall Foundation; Simons Foundation.
RESPONSABILITA’ EDITORIALISection Editor Neuroscience (2010-2013)
Review Editor Frontiers in Neuroscience (since 2014)
Editorial Board Current Opinion in Neurobiology (since 2017)
Editorial Board Neurobiology of Disease (since 2018-2020)
Advisory Board Neuroscience Next (since 2019)
Editorial Board Molecular Psychiatry (since 2020)
Editorial Board Current Research in Neurobiology (since 2020)
Review Editor eLife (since 2021)
Advisory Board EMBO Reports (since 2022)
ESPERTO COMITATI DI VALUTAZIONE2024 Comitato di valutazione scientifica del German Center for Mental Health (DZPG), Berlin, DE. 2023-2026 Comitato di valutazione scientifica del Donders Institute, Nijmegen, NL.
2023 Comitato di valutazione scientifica del Swiss Network for Dementia Research, CH. Valutatore per il Consiglio Europeo della Ricerca (ERC, COG selezione 2024). Comitato di tutoraggio della ricerca, Biozentrum Basel, CH. Comitato consultativo Fragile X International - FraXI. Comitato consultativo scientifico internazionale (iSAB) per l'Istituto di psichiatria e neuroscienze di Parigi, FR.
2022-oggi Valutatore per la Fondazione Lundbeck, DK.
Consiglio Lukas Lundin & Family Brain Tumor Research Center Foundation CHUV, Losanna, CH.
2022 Vicepresidente di commissione per il Consiglio europeo della ricerca (ERC, COG).
2021-2022 Valutatore per il Consiglio Europeo della Ricerca (ERC, STG, COG e ADG).
2021
Comitato scientifico consultativo del nuovo Centro internazionale di neuroscienze "Cajal" (CINC), FR.
Comitato di valutazione scientifica dell'Istituto interdisciplinare di neuroscienze di Bordeaux (IINS), FR.
Comitato di consulenza scientifica del Max-Planck-Institut of Neurobiology di Monaco, DE.
2021-oggi
Co-Presidente Comitato di selezione Fondazione Herbette, CH. Presidente Comitato di selezione Fondazione Donase, CH.
Membro delle seguenti commissioni: Fondazione Agassiz, Centro Svizzero di Tossicologia Umana Applicata,Fondazione Sandoz, Biowise, Centro Cantonale Autismo, Rete Lemanica di Sperimentazione Animale, CH.
Membro del Consiglio delle seguenti istituzioni svizzere: Centro di competenza bioinformatica, Istituto Sense, CH.
2020 Valutatore per i progetti della Deutsche Forschungsgemeinschaft (DFG), DE. Valutatore per il Consiglio europeo della ricerca (ERC, COG).
2019 Commissione per le assunzioni presso l'Università UniCamillus di Roma, IT.
2019-2021 Comitato consultativo ITN Syn2Psy Network Marie Curie Actions.
Commissione per l'uguaglianza, la diversità e l'integrazione presso l'Università di Losanna, CH.
2018 Commissione per le assunzioni presso l'Università di Roma San Raffaele Pisana, IT.
2017-oggi Commissione di selezione per la Fondazione Mia, IT.
2016-oggi Commissione per le assunzioni presso l'Università di Losanna (UNIL), l'Ospedale Universitario UNIL e l'Università di Ginevra, CH.
2014 Valutatore per il Consiglio europeo della ricerca (ERC, ADG) (decaduto nel 2016 e nel 2018).
2013-2020 Comitato consultativo per l'Istituto Leibniz di Neurobiologia, Magdeburgo, DE. 2013-2015 Commissione per le borse di studio a lungo termine EMBO, EMBL, DE.
2012 Commissione valutazione (Departmental Evaluation Board, DEB) del Departimento di Neuroscience presso l’Istituto Pasteur (2012).
2010-2016 Reclutamento personale docente presso l'Università Cattolica di Lovanio, BE.
2010-ogg Commissione per le assunzioni presso l'Università di Roma Tor Vergata, l'Università di Trento, l'Università diMilano, l'Università Foro Italico, IT.2013-oggi Consiglio consultativo dell'Associazione Fragile X International - FraXI.
REVISORE ESTERNO, PROMOZIONI ACCADEMICHE Yale University, USA, Boston University, USA; University of Geneva, Svizzera; Radboud University Nijmegen, Olanda; Academia Sinica, Taiwan; Institute Pasteur, Francia; University of Nottingham, UK; UT Southwestern Medical Center, USA; UC San Diego, USA; Baylor College of Medicine, USA; Stockholm University, Svezia; McGill University, Canada; UCLA, USA; Taiwan University, Taiwan; Freie Universität Berlin, Germania; NYU Abu Dhabi, Emirati Arabi.
ORGANIZZAZIONE CONVEGNI2023 EMBO Workshop Cell biology of the Nervous System: Long-term resilience and vulnerability, Crete, GR.
2019 1) 1st Stem Cells and Brain Organoids Training Course and Symposium, University of Lausanne/CHUV, CH; 2)EMBO Conference Cell Biology of the Neuron: Polarity, Plasticity and Regeneration, Crete, GR; 3) 7thEuropean Synapse Meeting. Department of Fundamental Neurosciences, Lausanne, CH; 4) AdvisoryBoard 19th Workshop on Fragile X and Neurodev. Disorders, Sorrento, IT.
2016 Gordon Research Conference. Cell Biology of the Neuron, Waterville Valley Resort, US.
2013 1) 10th International Conference on “Intracellular RNA Localization and Localized Translation”. Niagara-on-the-Lake, CA; 2) Kemali-IBRO Summer School on “RNA and Disease”, Cortona, IT.
2012 1) 8th FENS Forum of Neuroscience. Symposium on “The interplay between ERK and mTOR signaling in drug addiction and hyperdopaminergic disorders”, Barcelona, ES.
2011 1) FASEB-EMBO Meeting on “Intracellular RNA localization & Localized Translation”. Il Ciocco, Barga, IT; 2)23rd Biennal Meeting International Society for Neurochemistry (ISN). Symposium on “Molecular, Cellular and Behavioral Aspects of Mental Retardation and Autism”, Athens, GR.
2008 1) EMBO Conference Series on RNA and Disease. “RNA metabolism and associated pathologies”, Rome, IT.
2007 1) Italian Society for Neuroscience. “Mental retardation genes and synaptic dysfunctions”. Verona, IT; 2) 13th International Workshop on “Fragile X and X-linked Mental Retardation”, Venice, IT.
Session Chair:
2018 Federation of European Neuroscience Societies (FENS) 11th Forum of Neuroscience & European Molecular and Cellular Cognition Society (EMCCS-FENS) 8th Satellite Meeting, Berlino, DE.
2015 Federation of European Biochemical Societies (FEBS) 40th Congress “Control of Neuronal Function by Regulating Protein Homeostasis”, Berlino, DE.
2008 Cold Spring Harbor (CSH) Meeting “Translational Control”, New York, US
2002 European Molecular Biology Organization (EMBO) Workshop “Translational Control in Development and Neurobiology”, Cala Blava, Majorca, ES.
CONSIGLIERE SCIENTIFICO (ADVISORY BOARD) CONGRESSI RILEVANZA INTERNATIONALE2023 - Telethon Convention, Riva del Garda, IT.
2019 - 19th International Workshop on Fragile X and other Neurodevelopmental Disorders. Hotel Hilton Sorrento Palace, Sorrento, IT.
2016 - EPFL and W Science International Brain Forum, Losanna, CH
CONTRIBUTO ALLO SVILUPPO DELLA CARRIERA DEI GIOVANIFrancesca Zalfa: Associate Professor (tenured), University Campus Biomedico Rome, IT Daniele Di Marino: Associate Professor (tenured), University of Ancona, IT
Silvia De Rubeis: Associate Professor, Mount Sinai School of Medicine, NYC, US Pietro Pilo-Boyl: Assistant Professor (tenured), University of Bonn, DE
Alessio De Logu: Assistant Professor, King’s College London, UK Laura Pacini: AssistantProfessor, University of Rome Unicamillus, IT
Fiona Hollis: Assistant Professor, University of South Carolina, Columbia, USA Boris Eleuteri: Assistant Professor, Karolinska Institute, Stockholm SE Emanuela Pasciuto: Assistant Professor, Antwerp University/VIB, BE
Liliana Mannucci: Research Scientist, University Hospital Tor Vergata Roma, IT Clotilde Lauro: Research Scientist, University La Sapienza Rome, IT
Antonella Borreca: Research Scientist, CNR Milan, IT
Caroline Lacoux: Research Scientist, Institut de Pharmacologie, Nice Sophia Antipolis, FR Rossella Luca’: Research Scientist, CNR Rome, IT
Esperanza Fernandez: Senior scientist, VIB/University of Gent, BE Giorgio La Fata:Research Scientist, DSM Pharmaceutical, Basel, CH
Filomena Pirozzi: Postdoctoral Fellow, CW Reserve University, US Sarah Borrie: Postdoctoral fellow, VIB/KU Leuven, BE
Nicholas Rajan: Postdoctoral Fellow at Université Libre de Bruxelles, Brussels, BE Victor Briz: Postdoctoral fellow, University of Madrid, ES
Laura D’Andrea: Postdoctoral fellow, University of Milan, IT Denise Gastaldo: Postdoctoral fellow, Genentech, US
Nuria Dominguez-turza: Postdoctoral fellow at Harvard University, USA
Ilaria Napoli: Scientist UCB (Union Chimique Belge), London, UK Anna Vannelli: Clinical Data Manager, MSD Zurich, CH
Muna Hilal: Clinical Data Manager, Thonon-les-Bains Hospital, FR Adrian Lo: Clinical Data Manager, MSD Zurich, CH
Alexandros Kanellopoulos: Research Specialist, Nestlé, Lausanne, CH
Andrea Buzzi: Scientific administrator, European Medicines Agency, London, UK
RELATORE A CONFERENZE INTERNAZIONALI2024
SynGO Consortium Meeting (invitation accepted), Simons Foundation NYC, US.
Plenary Lecture, Gordon Research Conference (GRC) “Cell Biology of the Neuron”, Waterville Valley, US.
Gordon Research Conference (GRC) “Fragile X and Autism-Related Disorders”, Lucca, IT.
2023
Center for Biomedical Imaging (CIBM) Annual International Symposium, University of Lausanne, CH.
SynGO Consortium Meeting, Barcelona, ES.
Polish Neuroscience Society (PTBUN) 16th International Congress “Molecular biology of autism spectrum disorders”, Torun, PL.
Gruppo di Studio sui Tumori Cerebrali (GSTC) 2nd Scientific Meeting “Molecular and therapeutic breakthroughs in Brain Tumors”, Olbia, IT.
Gordon Research Conference (GRC) “Assembly and Function of Inhibitory Neurons in Health and Disease”, Les Diablerets, CH.
Gordon Research Conference (GRC) “Synapses and Circuits in Health and Disease”, Les Diablerets, CH.
European Molecular Cellular Cognition Society (EMCCS) workshop, Pula, Cagliari, IT, eTalk.
2022
Plenary Lecture, European Molecular Biology Organization (EMBO) Workshop “Molecular and physiological basis of behavioural/ cognitive defects in Neurodevelopmental disorders”, Bengaluru, IN.
Federation of European Neuroscience Societies (FENS) Forum, EMCCS Satellite Meeting, Paris, FR.
The Armenise Harvard Foundation 18th Symposium “Neuroscience at the Edge: Frontiers of Knowledge”, Varignana, IT.
Cell Symposia “The Biology of Neuropsychiatric Disorders”, Sitges, ES.
Scuola Normale Superiore Pisa Workshop “Mechanisms, Therapies and Biomarkers in Neurodevelopmental Disorders”, Pisa, IT.
Italy at International Society for Autism Research (INSAR), Como, IT.
NCCR Synapsy 4th Conference on the Neurobiology of Mental Health, Geneva, CH.
2021
The International British Neuroscience Association (BNA) 2021 Festival of Neuroscience, eTalk.
Lundbeck Foundation The Brain Prize meeting “Neurodevelopmental Disorders Mechanisms and Pathways to Treatment”, eTalk.
World Wide Neuro webinar, eTalk.
2020
Molecular and Cellular Cognition Society Workshop (MCCS), FJ.
Federation of European Neuroscience Societies (FENS), Glasgow, UK, eTalk.
2019
Plenary Lecture, Federation of European Biochemical Societies (FEBS) 44th Congress “From Molecules to Living Systems“, Krakow, PL.
Biology of Brain Disorders, Trinity College Dublin, Slane Castle-RockFarm, IRL. Fondation Les Treilles “Cilia and the Brain”, Tourtour, FR.
International Society for Neuroscience (ISN), Montreal, CA.
European Molecular Biology Organization (EMBO) Workshop “Cell Biology of the Neuron: Polarity, Plasticity and Regeneration”, Heraklion, GR.
European Molecular Biology Laboratory (EMBL) Conference “A Life for Science-Symposium
in Memory of Fotis Kafatos”, Heidelberg, DE.
Max-Planck-Institut für experimentelle Medizin Symposium “Quantitative Synaptology”, Goettingen, DE.
American College of Neuropsychopharmacology (ACNP) Annual Meeting, Orlando, US. Collaborative ResearchCenter 1080 International Symposium “Molecular and Cellular Mechanisms of Neural Homoeostasis”, MPI for Brain Research, Frankfurt, DE.
2018
European Molecular Biology Organization (EMBO) Conference “From synapses to memory : RNA based regulatory mechanisms”, Manesar, IN.
Cold Spring Harbor (CSH) Conference ASIA “Latest Advances in Development and Function of Neuronal Circuits”, Awaji, JP.
Gordon Research Conference (GRC) “Convergence and Divergence between Fragile X Syndrome and Autism Spectrum Disorders”, Barga, IT.
Swiss Society of Neuroscience (SSN), Zurich, CH.
European College of Neuropsychopharmacology (ECNP) “New Frontiers Meeting on neurodevelopmental disorders”, Nice, FR.
2017
European Molecular Biology Organization (EMBO) Conference “RNA Localization and Local Translation”, Barga, IT.
Cajal School “Advanced Techniques for Synapse Biology”, Bordeaux, FR.
MRC Centre for Neurodevelopmental Disorders Inaugural Symposium, London, UK. Gordon Research Seminar& Gordon Research Conference “Excitatory Synapses & Brain Function”, Les Diablerets, CH.
European Molecular Biology Organization (EMBO) meeting “Cell Biology of the neuron: Polarity, plasticity and regeneration”, Heraklion, GR.
Telethon Convention Symposium, Riva del Garda, IT.
Bordeaux NeuroCampus “Past, present, Future of Brain Research”, Bordeaux, France. 6th European Synapse Meeting, Milan, IT.
2016
International Child Neurology Association 2016. “Is Autism a treatable disorder?” Rome, IT. Gordon Research Conference (GRC) “Neural Development", Newport, Rhode Island, US. Gordon Research Conference (GRC)“Fragile X and Autism-Related Disorders”, Vermont, US. NCCR Synapsy “The Neurobiology of Mental Health”, Geneva, CH.
2015
Federation of European Biochemical Societies (FEBS) 40th Congress “Control of Neuronal Function by Regulating Protein Homeostasis”, Berlin, DE.
European Molecular Biology Organization (EMBO) Meeting “RNA localization & local translation”, Crete, GR.
NCCR Synapsy “Symposium on Autism”, Geneva, CH.
ENI-MIT “Synaptic basis of neuron network dysfunction in brain disorders”, Göttingen, DE. Gordon ResearchConference (GRC) “Excitatory Synapses & Brain Function”, Newport, US. Gordon Research Conference (GRC) “Neurotrophic Factors”, Newport, US.
GENCODYS 2nd International Conference “Integratice Networks in Intellectual Disabilities”, Crete, GR.
Winter Conference on “Neural Plasticity”, BRDO.
2014
College de France “Synapses and Psychiatry”, Paris, FR.
Cold Spring Harbor (CSH) Meeting “Axon Guidance, Synapse Formation and Regeneration”, NY, US.
Leibniz Institute for Neurobiology (LIN) 4th Symposium “Synaptic Function and Synaptic Pathology in Disease”, Tangermünde, DE.
RIKEN Brain Science Institute (BSI) Summer Program, Tokyo, JP.
Chinese Society of Biochemistry and Molecular Biology (CSBMB) 5th Advanced Summer School in Biochemistry and Molecular Cell Biology, Shanghai, CN.
Federation of European Neuroscience Societies (FENS) Symposium “Regulation of local protein synthesis in disease”, Milan, IT.
Gordon Research Conference (GRC) “Cell Biology of the Neuron”, Waterville Valley, US. RNA Society 19thAnnual Meeting, Québec, CA.
Wellcome Trust “Translational Control of Brain Function in Health and Disease”, London, UK. ONCODEFI 1stInternational Symposium “Cancer and Intellectual Disability”, Montpellier, FR.
2013
The Epithelial-Mesenchymal Transition International Association, Alicante, ES.
Federation of European Neuroscience Societies (FENS) “The Neurobiology of Synapses and their Dysfunction”, Stresa, IT.
European Molecular Biology Organization (EMBO) Members Meeting EMBL, Heidelberg, DE.
2012
Academia Sinica Neuroscience Program “Synapse Symposium”, Taipei, TP. Plenary Lecture, LeibnizInstitute for Neurobiology (LIND) Seminar, Mechelen, BE. The Malvin and Eleanor Mayer Lecture, MIT, Cambridge, US.
European Molecular Biology Organization (EMBO) Members Meeting. EMBL, Heidelberg, DE. Molecular and Cellular Cognition Society (MCCS), pre-SfN, New Orleans, US.
Plenary Lecture, Japan Neuroscience Society (JNS) 35th Annual Meeting, Nagoya, JP.
Gordon Research Conference (GRC) “Fragile X and Autism-related Disorders”, Stonehill College, North Easton, US.
Gordon Research Conference (GRC) “Cell Biology of the Neuron”, Waterville Valley, US. Workshop “mRNA fate: Life and Death of mRNA in the Cytoplasm”, Riva del Garda, IT.
Keystone Symposia “Synapses and Circuits: From Formation to Disease”, Steamboat Springs, Colorado US.
Bordeaux Neurocampus 10th Synapse Meeting, Bordeaux, FR.
NYU Abu Dhabi Conference “Genomics and Systems Biology II”, Abu Dhabi, UAE.
2011
The Synapse : From Physiology to Pathology, Stresa, IT. International Societyfor Neurochemistry (ISN), Athens, GR.
International Society for Neurochemistry (ISN) 10th Advanced School of Neurochemistry “Molecular basis of higher cognitive functions”, Delphi, GR.
European Molecular Biology Organization (EMBO) Meeting “Intracellular RNA Localization & Localized translation”, Barga, IT.
International Brain Research Organization, Florence, IT.
European Molecular Biology Organization (EMBO) Workshop “Cell biology of the Neuron: Polarity, Plasticity and Regeneration”, Heraklion, GR.
2010
European Molecular Biology Organization (EMBO) Workshop “RNA Control of Cell Dynamics”, Ein Gedi, IL.
Cantoblanco Workshop “Memory Formation and Memory Loss”, Madrid, ES. PLASTICISE Workshop, Pisa, IT.
Cold Spring Harbor (CSH) Meeting “Translational Control”, New York, US.
Federation of European Neuroscience Societies (FENS) & The European Journal of Neuroscience (EJN) Special Event “The Ever-Changing Brain”, Amsterdam, NL
European Molecular and Cellular Cognition Society (EMCCS) 4th Satellite Meeting at FENS, Amsterdam, NL.
KILI4X Conference “Fragile X Syndrome and Related Synaptopathies”, Edinburgh, Scotland, UK.
Gordon Research Conference (GRC) “Synaptic Transmission”, University of New England, Biddeford, US.
Federation of European Biochemical Societies (FEBS) & European Molecular Biology Organization (EMBO) Meeting “The Cytoskeleton in Development and Pathology”, Djuronas, Stockholm Archipelago, SE.
Armenise-Harvard Foundation “13th Annual Symposium on Neuronal Function and Neurologic Disorders”, Frascati, IT.
Keystone Symposia “Towards Defining the Pathophysiology of Autistic Behavior”, Snowbird, Utah, US.
2009
HHMI Janelia Farm Research Campus “Translation at the Synapse II”, Virginia, US.
Gordon Research Conference (GRC) “Excitatory Synapses & Brain Function”, Les Diablerets, CH.
International Society for Neurochemistry (ISN) 22nd Biennal Meeting, Busan, KR. Federation of American Societies for Experimental Biology (FASEB) & European Molecular Biology Organization (EMBO) SummerResearch Conference on "Intracellular RNA Transport and Localized Translation”, Saxtons River, US.
Plenary Lecture, French Neuroscience Society 9th Meeting, Bordeaux, FR.
Cold Spring Harbor Laboratory (CSHL) “New Developments in Fragile X Syndrome–From Basic Mechanisms to Therapeutics”, The Banbury Center, New York, US.
Institut de Neurobiologie Méditerranée (INMED) 7th Conference “Neuro-archeology: pre symptomatic architecture and signatures of neurological disorders”, La Ciotat, FR.
2008
Centre national de la recherche scientifique (CNRS) Conference Ladislav Tauc “Synaptic Plasticity and Brain Repair”, Gif sur Yvette, FR.
FRAXA Research Investigators Meeting, Durham, US.
Cold Spring Harbor (CSH) Meeting “Translational Control”, New York, US.
European Molecular Biology Organization (EMBO) Conference Series “RNA metabolism & Associated Pathologies”, Rome, IT.
International Neuroscience Winter Conference (IWNC) 10th Meeting, Solden, AT. 1st European Synapse Meeting, Bordeaux, FR.
Winter Conference on Neural Plasticity (WCNP), St. Lucia, LC.
2007
13th International Workshop “Fragile X and X-linked Mental Retardation”, Venice, IT. HHMI Janelia Farm Research Campus “Translation at the synapse”, Virginia, USA.
European Molecular Biology Organization (EMBO) Workshop “Intracellular RNA Localization & Localized Translation”, Pisa, IT.
International Brain Research Organizazion (IBRO) 7th World Congress of Neuroscience, Melbourne, AU.
International Winter Neuroscience Conference (IWNC) 9th Meeting, Sölden, AT.
2006
Cold Spring Harbor (CSH) Meeting “Translational Control”, New York, US.
Mini Nobel Symposium “The Active Dendrite”, Stockholm, SE.
2005
Institute of Genetics and Biophysics (IGB) 18th Workshop “Epigenetic Bases of Genome Reprogramming”, Capri, IT.
European Molecular Biology Organization (EMBO) Workshop “RNA control of neuronal function”, Kfar Blum, Upper Galilee, IL.
2004
Cold Spring Harbor (CSH) Meeting “Translational Control”, New York, US.
Gordon Research Conference (GRC) “Cell Biology of the Neuron”, Colby-Sawyer College, New Hampshire, US.
2003
Telethon Convention Symposium “Mental Retardation”, Riva del Garda, IT. “Genes & Development” Symposium, Edinburgh, Scotland, UK.
Fragile X Syndrome and X-Linked Mental Retardation, Nicosia, CY. Blankenese 23rdConference “Learning from the synapses”, Hamburg, DE.
Molecular Mechanisms of Neurodegeneration “From triplet repeat expansions to protein toxicity”, Milan, IT.
2002
Cold Spring Harbor (CSH) Meeting “Translational Control”, New York, US.
European Molecular Biology Organization (EMBO) Workshop “Translational Control in Development and Neurobiology”, Cala Blava, Majorca, ES.
Society For Biomaterials (SFB) Symposium “Mechanism of Cell Behaviour”, Tübingen, DE.
2001
Meeting “X-Linked Mental Retardation” 10th International Workshop, Frascati, Rome, IT. 2000 Cold Spring Harbor Laboratory (CSHL) Meeting “FMRP: what does it do?”, Banbury
Center, New York, US.
RELATORE PRESSO UNIVERSITÀ E ISTITUTI DI RICERCA2024
Ecole Normale Supérieure (invitation accepted), Paris, FR. University Medical CenterUtrecht (invitation accepted), Utrecht, NL. University Medical Center Mainz, (invitation accepted), Mainz, DE. UNISANTE Symposium, University of Lausanne, CH.
IDIBELL Seminar, University of Barcelona, ES. 2023 DNFSymposium, University of Lausanne, CH.
Paris Brain Institute ICM, Paris, FR.
2022
School of Biological Sciences, University of Maryland, Baltimore, US, eTalk. 2021 Center for Mind/Brain Sciences, University of Trento, Trento, IT, eTalk.
IGB-Institute of Genetics and Biophysics, CNR, Naples, IT, eTalk.
Simons Center for the Social Brain, Massachusetts Institute of Technology (MIT), US, eTalk. Center for Neuroscience and Cell Biology, University of Coimbra, PT, eTalk.
Schulich School of Medicine & Dentistry, Western University, CA, eTalk.
2020
Duke University, USA, eTalk.
Sorbonne Université, Paris, FR.
Grenoble Institut des Neurosciences, Grenoble, FR.
2019
Charité Universitätsmedizin, Berlin, DE.
CRG-Barcelona Biomedical Research Park, Barcelona, ES.
2018
Deutsches Zentrum für Neurodegenerative Erkrankungen, Bonn, DE.
Adolphe Merkle Institute (AMI) “Gender Equality: Myth and Reality“, Université de Fribourg, CH.
2017
Institute of Science and Technology, Klosterneuburg, AT. École polytechnique fédérale de Lausanne, CH.
Max Planck Florida Institute, Jupiter, USA. National Central University, Jongli, TP.
Zentrum für Molekulare Neurobiologie Hamburg, Hamburg University, DE. Cardiff University, Wales, UK.
Albert Einstein College of Medicine, NYC, US.
2016
University of Ulm, Ulm, DE.
University of Geneva, CH.
2015
Giga-neurosciences, Liège, BE. Scuola NormaleSuperiore, Pisa, IT.
2014
RIKEN Institute, Tokyo, JP.
Harvard University, Boston, US. Weizmann Institute, Rehovot,IL.
The Hebrew University of Jerusalem, Jerusalem, IL.
Innsbruck Medical University, Innsbruck, AT. Amsterdam University, Amsterdam, NL.
2013 The Wenner-Gren Institute Stockholm University, SE. University of Trieste, Trieste, IT.
Leibniz-Institute für Neurobiology, Magdeburg, DE. Max-Planck-Institute, Frankfurt, Heidelberg, DE. Italian Fragile X Association, Rome, IT.
King’s College London, UK. University of Bergen,Bergen, NO. MRC, Leicester, UK.
2012 MIT, Cambridge, US.
Instituto de Neurociencias, Alicante, ES. Hiroshima University, Hiroshima, JP.
2011 Irvine University, US. UCSD, San Diego, US. Scripps, San Diego, US. UCLA, LosAngeles, US. UC Davis, Davis, US.
2010 MRC London, UK.
Utrecht University, NL.
Mount Sinai, New York City, US. Heidelberg University,Heidelberg, DE.
2009 Institut Chochin, Paris, FR.
New England Biolabs, Ipswich, MA, USA. University of Brussels, Brussels, BE.
2008 University of Toulouse Paul Sabatier/CNRS, FR. Amsterdam University, Amsterdam, NL.
2007 École Normale Supérieure, Paris, FR.
Child Study Center, Yale University, New Haven, US. Victor Chang Research Institute, Sidney, AU.
2006 KU University of Leuven, Flanders Institute of Biotechnology (VIB) Leuven, BE. Institute Pasteur, Paris, FR.
École Normale Supérieure, Paris, FR.
National Institute of Child Health and Human Development (NICHD), Washington, US. University of Hamburg-Eppendorf, Institute of Anatomy, Hamburg, DE.
Center for Genomic Regulation, Gene Regulation Program, Barcellona, ES. Max Planck Institute for Biophysical Chemistry, Göttingen, DE.
2005 Department of Biological Sciences, University of Cyprus, Nicosia, CY. Child Study Center, Yale University, New Haven, US.
University of Massachusetts, Medical School, Worcester, US. 2004 Massachusetts Institute of Technology, Cambridge, MA, US.
Department of Cell Biology, Yale University School of Medicine, New Haven, US. University Paul Sabatier-CNRS, Toulouse, FR.
2003 University of Edinburg, Edinburg, SCT.
2002 Institute of Experimental Pathology, ZMBE, University of Münster, DE. Erasmus University, Rotterdam, NL.
Tübingen University, Tübingen, DE.
DIVULGAZIONE DELLA RICERCA (selezionate tra quelle avvenute ultimi 10 anni)
2024 Semaine du Cerveau, Università di Losanna e Ospedale Universitario CHUV in collaborazione con l'associazione di famiglie Autisme Suisse Romande. “Understanding Autism: A Journey of Awareness and Acceptance-Beyond a Label".
Semaine du Cerveau, University of Lausanne (Marzo, Losanna, Svizzera). https://news.unil.ch/display/1674035207382
2023 FRAXAS Open day presso il Dipartimento di Neuroscienze Fondamentali per le famiglie bambini svizzeri ed italiani con la Sindrome dell'X Fragile. Esperimenti, conferenze e visita dei laboratori (Settembre, Losanna, Svizzera).
https://fraxas.ch/journee-portes-ouvertes-2023/
2022 Italian Fragile X Association Riunione annuale dell'Associazione (Napoli, IT).
SPECTRUM interview.
https://www.spectrumnews.org/news/the-cloudy-connection-between-fragile-x-and-cancer/
UNIL – L’ACTU : L’X fragile, bouclier contre le cancer du cerveau. https://www.myscience.ch/fr/news/2022/l_x_fragile_bouclier_contre_le_cancer_du_cerveau- 2022-unil
Migros Magazine : Vers une science sans cobayes. https://corporate.migros.ch/fr/Magazine/2022/01/experimentation-animale-votation-
recherche- progres.html
2021 RAI TV Telethon Foundation Marathon (IT).
Conferenza delle Associazioni Familiari e dei Coordinatori Provinciali della Fondazione Telethon: Frontiere della ricerca sulle malattie genetiche rare (virtuale, Ottobre).
Life Sciences, Pharma & Biotech Summit, Il Sole 24 ORE (virtuale, Iuglio)
Riunione FRAXAS (Svizzera). Sviluppo infantile e sindrome dell'X fragile. Dai modelli biologici alle terapie (virtuale, Maggio).
Associazione Italiana Sindrome X Fragile. Progetto "Formazione e inclusione" (virtuale, Maggio).
2019 Women in Science 7th Annual Lecture & Luncheon, Fairmont Le Montreux Palace (novembre, Montreux, Svizzera).
Assemblea annuale dell'Associazione Italiana X Fragile. Panoramica sulla ricerca attuale su FXS (Aprile, Roma, Italia).
Empowering Women in Science-Panel Discussion al Medtronic (Marzo, Tolochenaz, Svizzera).
2018 FRAXAS-D. Open day presso il Dipartimento di Neuroscienze Fondamentali per le famiglie e i bambini svizzeri con la Sindrome dell'X Fragile. Esperimenti, conferenze e visita dei laboratori (Settembre, Losanna, Svizzera).
2017 Riunione annuale delle Associazioni Europee delle famiglie X Fragile (Novembre, Nyon, Svizzera).
2014 + 16 Eventi della Fondazione Regina Elisabetta in presenza della Principessa Astrid del Belgio, Palazzo Reale diBruxelles (Belgio). Interviste e comunicati stampa (giornali e radio italiani, belgi, svizzeri).
FINANZIAMENTI
(University of Lausanne, Switzerland; University of Rome Tor Vergata, Italy):
2023-2026 Swiss National Science Foundation (SNSF) “Mitochondrial dysregulation and sociability: the role of ARALAR/SLC25A/AGC1” (CH).
2023-2025 Fondazione Italiana per l’Autismo (FIA) “Valutazione delle atipie olfattive nei bambini con autismo idiopatico e monogenico: verso nuovi strumenti diagnostici e terapie personalizzate” (IT).
2023 Novartis Foundation for medical-biological research “An Integrated Platform for High- Throughput Drug Discovery for Autism – Fly Avatar Screen” Platform (FASP) (CH).
Fonds Dr. E. Rub, Faculty Biology and Medicine, “Characterization of the cortico-striatal social network by micro-electrode arrays” UNIL (CH).
2023-2025 Progetti di Ricerca di rilevante interesse nazionale (Prin)/Italian Ministry University (MUR)
Gait signature in Fragile X Syndrome: an innovative translational approach” (IT).
2021-2024 ERA-NET NEURON Joint Transnational Research Projects on Sensory Disorders (EU).
2021-2023 Telethon (Italian Charity Foundation). “A new RNA-based therapy for the Fragile X Syndrome”. GGP20137 (IT).
2019-2022 Swiss National Science Foundation (SNSF) “Dissecting specific circuits of social cognition in intellectual disabilities: from molecules to behavior” (CH).
2019-2020 Fondazione Terzo Pilastro Internazionale “Un nuovo approccio terapeutico per il miglioramento della funzionalità neuronale nella Sindrome dell’X Fragile” (IT).
Angelini S.p.A. (IT) “Ameliorating synaptic plasticity and behavior in Fragile X Syndrome" (IT).
2018 Financement Recherche Fondamentale -Faculty of Biology and Medicine, UNIL (CH).
2018-2022 SNSF NCCR- Synapsy “Cognitive flexibility in Fragile X Syndrome” (CH).
2018 Novartis Foundation for medical-biological research. “The Domino-Drosophila ensemble for the functional validation of new ID genes” (CH).
2016-2018 University of Lausanne - Start-up grant. “From molecules to behavior: Disentangling Fragile X, Autism Spectrum Disorders and Schizophrenia” (CH).
2018-2022 Progetti di rilevante interesse nazionale (Prin)/Italian Ministry University (MUR) “The APP- mitochondria axis in iPSCs derived-neurons from Fragile X (201789LFKB) (IT).
2015-2018. Department of Defense (USA). Investigator-Initiated Research Award. “Exaggerated Cap Dependent Translation as a Mechanism for Corticostriatal Dysfunction in Fragile X Syndrome
Model Mice” (W81XWH-15-1-0361) (US).
2009-2015
(VIB-K University Leuven, BE & University of Rome Tor Vergata, IT) :
• Flemish Institute for Biotechnology (VIB). “Cellular and Molecular Studies of Synaptic Plasticity in the context of the Fragile X Syndrome”.
• FP7-HEALTH-2009. “Synaptic Systems: dissecting brain function in health and disease.
• SYNSYS. Collaborative Project; Large-scale integrating project; HEALTH-2009-2.1.2-1”.
• Flanders Research Foundation (FWO). “Molecular, biochemical and genetic studies of the autism in the context of the Fragile X Syndrome”.
• Hercules Grant for large instruments. “Optical measurement of neural activity in vivo and with (sub)cellular resolution”.
• Opening the future (KU Leuven). “Understanding and ameliorating autism spectrum disorders: from bed to bench and back”.
• Flanders Research Foundation (FWO). “Linking activity-dependent mRNA translation at synapses to spine remodeling: insights into Mental Retardation”
• Flanders Research Foundation (FWO). “The Fragile X Mental Retardation Protein FMRP controls the
earliest steps of Epithelial to Mesenchymal Transition, an important bottleneck in cancer progression and metastasis formation”.
• Flanders Research Foundation (FWO). Coordinator (two other units included). “The use of induced pluripotent stem cells in the study of two patient-specific disease models for neurodevelopmental disorders: the Fragile X syndrome and MECP2-related disorders”.
• Intra-University Funds (KU Leuven). “The role of the Fragile X Mental Retardation Protein as a possible prognostic marker to gauge Cancer Metastasis”.
• Flanders Research Foundation (FWO). Molecular and biochemical insights of the Fragile X Mental Retardation Protein: effects on tumor progression and metastasis formation”.
• Flanders Research Foundation (FWO). “Role/s of CYFIP1 in brain development and implications in neurodevelopmental disorders”.
• Marie Curie Actions (FP7-PEOPLE-2010-IEF) “Characterization of the molecular components of synapses in Fragile-X mental retardation syndrome: new insights into the FMRP regulatory mechanisms”.
• ERA-NET NEURON Joint Transnational Call for “European Research Projects on Mental Disorders” TAO2-FMRP pathway in Brain connectivity in ASD”.
• Marie Curie Initial Training Network (FP7-People). “BrainTrain: Integrative neuroscience school on brain function and disease”.
• K University of Leuven (start-up grant) “Cellular and Molecular Studies of Synaptic Plasticity in the context of the Fragile X Syndrome”.
• Queen Elisabeth Foundation (FMRE Belgium). “CYFIP1-pathies: shared pathways in intellectual disabilities and psychiatric disorders”.
• Queen Elisabeth Foundation. “mRNA metabolism at synapses and spine remodeling: insights into fragile X, autism and Schizophrenia”.
• Foundation for Alzheimer Research Belgium (SAO-FRMA). “Molecular correlations between Alzheimer's Disease and Fragile X Syndrome”.
• Foundation for Alzheimer Research Belgium (SAO-FRMA). “Identification of shared pathways between Intellectual Disabilities and Alzheimer Disease”.
• Flanders Research Foundation (FWO). “Characterization of the GABAergic system in the Fragile X syndrome” (Coordinator Frank Kooy).
• Foundation Jerome Lejeune “Targeting APP-ADAM10 pathway: a peptide-based therapy for FXS”.
• Flanders Research Foundation (FWO). “Study of the role of the nuclear export factor 5 (NXF5) in neuronal mRNA transport and metabolism, and its involvement in mental retardation” (coordinator Guy Froyen).
• CARIPLO (Bank Foundation). “Shaping and reshaping the synapses: from physiology to Intellectual Disability Syndromes”.
• CARIPLO (Bank Foundation). “A multilevel approach to study neuronal and synaptic development: two processes impaired in mental retardation”.
• Compagnia di San Paolo (Bank Foundation), Neuroscience Program. “Molecular correlations between Alzheimer Disease and Fragile X Syndrome: insights into neuronal development, mental retardation and neurodegeneration”.
• Foundation Jerome Lejeune. “mRNA metabolism in Fragile X Syndrome: The role of PSD-95 mRNA in spine structure, function and plasticity”.
• Telethon (Italian Charity Foundation). “Mechanisms of reactivation of the FMR1 gene and analysis of pathways involved in the pathogenesis of fragile X syndrome: towards a drug-based therapy”.
PRECEDENTI IL 2008 (Fondazione Santa Lucia, University of Rome, Italy)
TELETHON (Fondazione Italiana); Italian National Institute of Health (Istituto Superiore di Sanità); Italian Ministry of University (FIRB, Fondo per gli Investimenti della Ricerca di Base); FIRB International in collaboration with M.I.T. (USA); National Alliance for Autism Research (USA); Italian Ministry of University (COFIN); Fondazione Compagnia di San Paolo (Italia); FRAXA (USA).
FINANZIAMENTI OTTENUTI PER LO SVOLGIMENTO DI CONFERENZE INTERNAZIONALI
2023 EMBO meeting Cell biology of the nervous system: Long-term resilience and vulnerability (EMBO) Heraklion, GR.
Fonds Dr. E. Rub UNIL (CH) supporting EMBO meeting Cell biology of the nervous system: Long-term resilience and vulnerability (EMBO) Heraklion, GR.
Fonds Dr. E. Rub UNIL (CH) supporting FRAXAS Open day at the Department of Fundamental Neurosciences for Swiss and Italian families and children with Fragile X Syndrome.
2019 EMBO meeting “Cell Biology of the Neuron: Polarity, plasticity and regeneration”. Heraklion, GR.
1st Stem Cells and Brain Organoids Training Course and Symposium, University ofLausanne/CHUV, CH.
7th European Synapse Meeting. Department of Fundamental Neuroscience, Lausanne, CH.
2016 Gordon Research Conference “Cell Biology of the Neuron”. Waterville. New Hampshire, US.
2013 Kemali-IBRO Summer School on “RNA and Disease (IBRO), Cortona, IT.
2011 EMBO meeting “Intracellular RNA localization & Localized translation” (EMBO) Barga, IT.
2008 EMBO Conference Series on RNA and Disease. “RNA metabolism and associated pathologies” (EMBO) Rome, IT.
COLLABORAZIONI IN ATTOProf. Seth Grant (University of Edinburgh, UK); Profs.Giovanni Neri, Roberto Pallini and Elisabetta Tabolacci (Università Cattolica di Roma, IT), Profs Monica Di Luca and Fabrizio Gardoni (University of Milan, IT); Prof Guus Smit (Amsterdam University, NL), Prof. Eric Klann (New York University, US), Prof. Carlo Rivolta (University of Basel, CH), Prof. Andrea Superti Furga and Prof. Nadia Chabane (University Hospital Lausanne, CH), Dr. Paola Bezzi (University of Lausanne).